Mammen Mathai 4
4 · JOHNSON & JOHNSON · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Mammen Mathai
EVP, Pharm, R&D
Transactions
- Exercise/Conversion
Common Stock
2022-02-14+7,418→ 39,895 total - Tax Payment
Common Stock
2022-02-14$168.85/sh−2,335$394,265→ 37,560 total - Exercise/Conversion
Restricted Share Units
2022-02-14−7,418→ 0 totalFrom: 2022-02-11→ Common Stock (7,418 underlying)
Footnotes (2)
- [F1]Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
- [F2]Shares withheld for payment of taxes upon vesting of Restricted Share Units.